Fonte: Genetics in medicine. Unidade: FM
Assuntos: AGENTES DOPAMINÉRGICOS, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAIDA, Ken et al. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals. Genetics in medicine, v. 25, n. 1, p. 90-102, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53033. Acesso em: 16 out. 2024.APA
Saida, K., Marootain, R., Sengoku, T., Mitani, T., Pagnamenta, A. T., Marafi, D., et al. (2023). Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals. Genetics in medicine, 25( 1), 90-102. doi:10.1016/j.gim.2022.09.010NLM
Saida K, Marootain R, Sengoku T, Mitani T, Pagnamenta AT, Marafi D, Zaki MS, O'Brien TJ, Karimiani EG, Kaiyrzhanov R, Ceroni JRM, Kim CA. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals [Internet]. Genetics in medicine. 2023 ; 25( 1): 90-102.[citado 2024 out. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53033Vancouver
Saida K, Marootain R, Sengoku T, Mitani T, Pagnamenta AT, Marafi D, Zaki MS, O'Brien TJ, Karimiani EG, Kaiyrzhanov R, Ceroni JRM, Kim CA. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals [Internet]. Genetics in medicine. 2023 ; 25( 1): 90-102.[citado 2024 out. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53033